Kiora Pharma Stock Price, News & Analysis
Company Description
Kiora Pharma (OTC Link: KPHMW) is a publicly traded company.
On a trailing twelve-month basis, Kiora Pharma reported revenue of $16.0M with net income of $3.6M and diluted earnings per share of $0.87. The company operates at a net profit margin of 22.4%.
This page provides a comprehensive overview of KPHMW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SEC Filings
Kiora Pharma has filed 5 recent SEC filings, including 3 Form 4, 2 Form 8-K. The most recent filing was submitted on April 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KPHMW SEC filings →
Financial Highlights
Kiora Pharma generated $16.0M in revenue over the trailing twelve months, operating income reached $4.5M (28.1% operating margin), and net income was $3.6M, reflecting a 22.4% net profit margin. Diluted earnings per share stood at $0.87. The company generated $8.6M in operating cash flow. With a current ratio of 4.94, the balance sheet reflects a strong liquidity position.